| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | SAREPTA THERAPEUTICS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$220,000 | |
| 2026 | SAREPTA THERAPEUTICS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$270,000 | |
| 2025 | SAREPTA THERAPEUTICS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$230,000 | |
| 2025 | SAREPTA THERAPEUTICS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$430,000 | |
| 2025 | SAREPTA THERAPEUTICS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$260,000 | |
| 2025 | SAREPTA THERAPEUTICS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$320,000 | |
| 2024 | SAREPTA THERAPEUTICS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$290,000 | |
| 2024 | SAREPTA THERAPEUTICS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$250,000 | |
| 2024 | SAREPTA THERAPEUTICS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$240,000 | |
| 2024 | SAREPTA THERAPEUTICS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$240,000 |
| Firm | Filings | Expenses |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | 52 | $7,630,000 |
| Issue | Activities |
|---|---|
| Health Issues | 51 |
| Budget/Appropriations | 17 |
| Taxation/Internal Revenue Code | 14 |
| Medicare/Medicaid | 11 |
| Science/Technology | 10 |
| Copyright/Patent/Trademark | 3 |
| Pharmacy | 3 |
| Trade (domestic/foreign) | 1 |